Literature DB >> 25624150

Dopamine transporter imaging in the aged rat: a [¹²³I]FP-CIT SPECT study.

Aida Niñerola-Baizán1, Santiago Rojas2, Núria Roé-Vellvé3, Francisco Lomeña4, Domènec Ros5, Javier Pavía6.   

Abstract

INTRODUCTION: Rodent models are extensively used to assess the biochemical and physiological changes associated with aging. They play a major role in the development of therapies for age-related pathologies such as Parkinson's disease. To validate the usefulness of these animal models in aging or age-related disease research, the consistency of cerebral aging processes across species must be evaluated. The dopaminergic system seems particularly susceptible to the aging process. One of the results of this susceptibility is a decline in striatal dopamine transporter (DAT) availability.
METHODS: We sought to ascertain whether similar age changes could be detected in-vivo in rats, using molecular imaging techniques such as single photon emission computed tomography (SPECT) with [(123)I]FP-CIT.
RESULTS: A significant decrease of 17.21% in the striatal specific uptake ratio was observed in the aged rats with respect to the young control group.
CONCLUSIONS: Our findings suggest that age-related degeneration in the nigrostriatal track is similar in humans and rats, which supports the use of this animal in models to evaluate the effect of aging on the dopaminergic system. ADVANCES IN KNOWLEDGE AND IMPLICATIONS FOR PATIENT CARE: Our findings indicate that age-related degeneration in the nigrostriatal track is similar in humans and rats and that these changes can be monitored in vivo using small animal SPECT with [(123)I]FP-CIT, which could facilitate the translational research in rat models of age related disorders of dopaminergic system.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Dopamine; Dopamine transporter (DAT); Rat; Single positron emission computed tomography (SPECT); [(123)I]FP-CIT

Mesh:

Substances:

Year:  2015        PMID: 25624150     DOI: 10.1016/j.nucmedbio.2014.12.020

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  5 in total

Review 1.  How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?

Authors:  Darryl Bannon; Anne M Landau; Doris J Doudet
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 5.081

2.  Effect of sex on aging-related decline of dopamine transporter in healthy subjects.

Authors:  Seunghyeon Shin; Hyun-Yeol Nam; Myung Jun Lee; Kyoungjune Pak; Keunyoung Kim; In Joo Kim
Journal:  Ann Nucl Med       Date:  2020-10-14       Impact factor: 2.668

3.  Dynamic Changes in Striatal mGluR1 But Not mGluR5 during Pathological Progression of Parkinson's Disease in Human Alpha-Synuclein A53T Transgenic Rats: A Multi-PET Imaging Study.

Authors:  Tomoteru Yamasaki; Masayuki Fujinaga; Kazunori Kawamura; Kenji Furutsuka; Nobuki Nengaki; Yoko Shimoda; Satoshi Shiomi; Makoto Takei; Hiroki Hashimoto; Joji Yui; Hidekatsu Wakizaka; Akiko Hatori; Lin Xie; Katsushi Kumata; Ming-Rong Zhang
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

4.  Degree of dopaminergic degeneration measured by 99mTc-TRODAT-1 SPECT/CT imaging.

Authors:  Ling Lin; Jing Ye; Han Zhang; Zhong-Fu Han; Zhi-Hong Zheng
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

5.  Combination of In Vivo [123I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum.

Authors:  So Hyeon Park; Yoo Sung Song; Byung Seok Moon; Byung Chul Lee; Hyun Soo Park; Sang Eun Kim
Journal:  Exp Neurobiol       Date:  2019-10-31       Impact factor: 3.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.